Skip to content

Impact BioMedical, INC.

IBO

CIK 0001834105

← back to feed
Revenue (TTM)
$82K
−36.0% YoY Q1 May 2026
Net Income (TTM)
−$19.37M
+52.1% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.43
+83.5% YoY Q1 May 2026
Gross Margin
-417.1%
Q1 May 2026
Operating Margin
-6,585.4%
Q1 May 2026
Net Margin
-23,622.0%
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$20K
Q1 May 2026
Total Debt
$11.9M
Q1 May 2026
Shares Outstanding
107.82M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings